Beta Bionics (BBNX) Other Non-Current Liabilities (2023 - 2026)

Beta Bionics has disclosed Other Non-Current Liabilities across 4 years of filings, most recently posting $1.6 million for Q2 2026.

• In Q2 2026, Other Non-Current Liabilities rose 61.13% year-over-year to $1.6 million; the TTM figure through Jun 2026 stood at $1.6 million (up 61.13% YoY), while the FY2025 annual figure was $1.5 million, down 96.55% from the prior year.
• Other Non-Current Liabilities came in at $1.6 million for Q2 2026 at Beta Bionics, up from $1.6 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $44.9 million in Q4 2024 to a low of $400000.0 in Q1 2025.
• Average Other Non-Current Liabilities over 4 years is $11.2 million, with a median of $1.6 million recorded in 2025.
• Year-over-year, Other Non-Current Liabilities plunged 96.55% in 2025 and jumped 289.5% in 2026.
• Over 4 years, Other Non-Current Liabilities stood at $37.6 million in 2023, then rose by 19.5% to $44.9 million in 2024, then tumbled by 96.55% to $1.5 million in 2025, then increased by 5.3% to $1.6 million in 2026.
• Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $1.6 million in Q2 2026, $1.6 million in Q1 2026, and $1.5 million in Q4 2025.